Epidemiology in older adults of the comorbidity of COVID-19 and type 2 diabetes
Older adults were the segment of the population most affected by the COVID-19 pandemic. Type 2 diabetes (DBT2) also has a high prevalence in this age group, and its preexistence increases susceptibility, severity, and mortality from COVID-19. The objectives of this work were to calculate and compare...
Guardado en:
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Artículo revista |
| Lenguaje: | Español |
| Publicado: |
Universidad Nacional Córdoba. Facultad de Ciencias Médicas. Secretaria de Ciencia y Tecnología
2023
|
| Materias: | |
| Acceso en línea: | https://revistas.unc.edu.ar/index.php/med/article/view/42712 |
| Aporte de: |
| id |
I10-R327-article-42712 |
|---|---|
| record_format |
ojs |
| institution |
Universidad Nacional de Córdoba |
| institution_str |
I-10 |
| repository_str |
R-327 |
| container_title_str |
Revista de la Facultad de Ciencias Médicas de Córdoba |
| language |
Español |
| format |
Artículo revista |
| topic |
Covid-19 Diabetes Mellitus Type 2 older adults Epidemiology Covid-19 Diabetes Mellitus Tipo 2 Adultos Mayores epidemiologia |
| spellingShingle |
Covid-19 Diabetes Mellitus Type 2 older adults Epidemiology Covid-19 Diabetes Mellitus Tipo 2 Adultos Mayores epidemiologia Ferreyra Pisani, V Díaz-Gerevini, GT Priotto, S López, CB Pigino, G Quiroga, P Repossi, G Epidemiology in older adults of the comorbidity of COVID-19 and type 2 diabetes |
| topic_facet |
Covid-19 Diabetes Mellitus Type 2 older adults Epidemiology Covid-19 Diabetes Mellitus Tipo 2 Adultos Mayores epidemiologia |
| author |
Ferreyra Pisani, V Díaz-Gerevini, GT Priotto, S López, CB Pigino, G Quiroga, P Repossi, G |
| author_facet |
Ferreyra Pisani, V Díaz-Gerevini, GT Priotto, S López, CB Pigino, G Quiroga, P Repossi, G |
| author_sort |
Ferreyra Pisani, V |
| title |
Epidemiology in older adults of the comorbidity of COVID-19 and type 2 diabetes |
| title_short |
Epidemiology in older adults of the comorbidity of COVID-19 and type 2 diabetes |
| title_full |
Epidemiology in older adults of the comorbidity of COVID-19 and type 2 diabetes |
| title_fullStr |
Epidemiology in older adults of the comorbidity of COVID-19 and type 2 diabetes |
| title_full_unstemmed |
Epidemiology in older adults of the comorbidity of COVID-19 and type 2 diabetes |
| title_sort |
epidemiology in older adults of the comorbidity of covid-19 and type 2 diabetes |
| description |
Older adults were the segment of the population most affected by the COVID-19 pandemic. Type 2 diabetes (DBT2) also has a high prevalence in this age group, and its preexistence increases susceptibility, severity, and mortality from COVID-19. The objectives of this work were to calculate and compare the main epidemiological variables, between groups with DBT2 and without DBT2 in the study population, before and during the COVID-19 pandemic. To determine if there is an association of higher mortality from COVID-19 with the presence of DBT2 in this population of older adults.
Retrospective observational study (2018-2022) of medical records (n=1020) of older adults (≥65 years) treated at the "San Ricardo Pampuri" Center in Villa Carlos Paz. They were statistically analyzed by ANOVA test for quantitative data and Chi-square for categorical data using Infostat (α=0.05). The ethical norms of confidentiality and anonymity were respected.
Population data: Gender distribution=62% male/38% female. 47% of the population suffered from DBT2. Total COVID-19 prevalence: 46% of the population (469 cases) during the study period. COVID-19 incidences (%, DBT2 and non-DBT2 patients respectively): 2020: 25.15 vs 15.78; 2021: 22.95 vs. 14.73; 2022: 11.26 vs. 5.38. COVID-19 mortality (%): Total Average=0.63; in DBT2= 1.00 vs. No DBT2=0.32. 72% of the deceased had DBT2. Annual mortality and fatalities from COVID-19 were higher for those with DBT2. In 2020 and 2021 COVID-19 was the leading cause of death in the population studied. Excess Mortality: Average General Mortality (%) pre-pandemic (2018-2019)=1.86 vs pandemic (2020-2022)=2.72 (46% increase). Average age of death from COVID-19: DBT2=76.4; Not DBT2=84.1. 83% of deceased diabetic patients (2020-2022) were not vaccinated against SARS-COV-2.
The COVID-19 pandemic had a negative impact on the population parameters studied, with these increases being greater in the group with DBT2. An increased mortality risk for COVID-19 was observed in patients with T2DM. In 2022, there was a large decrease in incidence, mortality, and lethality (general and specific for COVID-19) compared to 2021. The improvement of the variables in 2022 coincides with more than 80% of the population covered with vaccines (≥ 2 doses) against SARS-COV-2 |
| publisher |
Universidad Nacional Córdoba. Facultad de Ciencias Médicas. Secretaria de Ciencia y Tecnología |
| publishDate |
2023 |
| url |
https://revistas.unc.edu.ar/index.php/med/article/view/42712 |
| work_keys_str_mv |
AT ferreyrapisaniv epidemiologyinolderadultsofthecomorbidityofcovid19andtype2diabetes AT diazgerevinigt epidemiologyinolderadultsofthecomorbidityofcovid19andtype2diabetes AT priottos epidemiologyinolderadultsofthecomorbidityofcovid19andtype2diabetes AT lopezcb epidemiologyinolderadultsofthecomorbidityofcovid19andtype2diabetes AT piginog epidemiologyinolderadultsofthecomorbidityofcovid19andtype2diabetes AT quirogap epidemiologyinolderadultsofthecomorbidityofcovid19andtype2diabetes AT repossig epidemiologyinolderadultsofthecomorbidityofcovid19andtype2diabetes AT ferreyrapisaniv epidemiologiaenadultosmayoresdelacomorbilidaddecovid19ydiabetestipo2 AT diazgerevinigt epidemiologiaenadultosmayoresdelacomorbilidaddecovid19ydiabetestipo2 AT priottos epidemiologiaenadultosmayoresdelacomorbilidaddecovid19ydiabetestipo2 AT lopezcb epidemiologiaenadultosmayoresdelacomorbilidaddecovid19ydiabetestipo2 AT piginog epidemiologiaenadultosmayoresdelacomorbilidaddecovid19ydiabetestipo2 AT quirogap epidemiologiaenadultosmayoresdelacomorbilidaddecovid19ydiabetestipo2 AT repossig epidemiologiaenadultosmayoresdelacomorbilidaddecovid19ydiabetestipo2 |
| first_indexed |
2024-09-03T21:04:51Z |
| last_indexed |
2024-09-03T21:04:51Z |
| _version_ |
1809210400506380288 |
| spelling |
I10-R327-article-427122023-10-19T21:19:44Z Epidemiology in older adults of the comorbidity of COVID-19 and type 2 diabetes Epidemiología en adultos mayores de la comorbilidad de COVID-19 y diabetes tipo 2 Ferreyra Pisani, V Díaz-Gerevini, GT Priotto, S López, CB Pigino, G Quiroga, P Repossi, G Covid-19 Diabetes Mellitus Type 2 older adults Epidemiology Covid-19 Diabetes Mellitus Tipo 2 Adultos Mayores epidemiologia Older adults were the segment of the population most affected by the COVID-19 pandemic. Type 2 diabetes (DBT2) also has a high prevalence in this age group, and its preexistence increases susceptibility, severity, and mortality from COVID-19. The objectives of this work were to calculate and compare the main epidemiological variables, between groups with DBT2 and without DBT2 in the study population, before and during the COVID-19 pandemic. To determine if there is an association of higher mortality from COVID-19 with the presence of DBT2 in this population of older adults. Retrospective observational study (2018-2022) of medical records (n=1020) of older adults (≥65 years) treated at the "San Ricardo Pampuri" Center in Villa Carlos Paz. They were statistically analyzed by ANOVA test for quantitative data and Chi-square for categorical data using Infostat (α=0.05). The ethical norms of confidentiality and anonymity were respected. Population data: Gender distribution=62% male/38% female. 47% of the population suffered from DBT2. Total COVID-19 prevalence: 46% of the population (469 cases) during the study period. COVID-19 incidences (%, DBT2 and non-DBT2 patients respectively): 2020: 25.15 vs 15.78; 2021: 22.95 vs. 14.73; 2022: 11.26 vs. 5.38. COVID-19 mortality (%): Total Average=0.63; in DBT2= 1.00 vs. No DBT2=0.32. 72% of the deceased had DBT2. Annual mortality and fatalities from COVID-19 were higher for those with DBT2. In 2020 and 2021 COVID-19 was the leading cause of death in the population studied. Excess Mortality: Average General Mortality (%) pre-pandemic (2018-2019)=1.86 vs pandemic (2020-2022)=2.72 (46% increase). Average age of death from COVID-19: DBT2=76.4; Not DBT2=84.1. 83% of deceased diabetic patients (2020-2022) were not vaccinated against SARS-COV-2. The COVID-19 pandemic had a negative impact on the population parameters studied, with these increases being greater in the group with DBT2. An increased mortality risk for COVID-19 was observed in patients with T2DM. In 2022, there was a large decrease in incidence, mortality, and lethality (general and specific for COVID-19) compared to 2021. The improvement of the variables in 2022 coincides with more than 80% of the population covered with vaccines (≥ 2 doses) against SARS-COV-2 Los adultos mayores fueron el segmento de población más afectado por la pandemia de COVID-19. La diabetes tipo 2 (DBT2) también tiene una alta prevalencia en este grupo etario y su preexistencia aumenta la susceptibilidad, gravedad y mortalidad por COVID-19. Los objetivos de este trabajo fueron calcular y comparar las principales variables epidemiológicas, entre grupos con DBT2 y sin DBT2 en la población estudiada, antes y durante la pandemia de COVID-19. Determinar si existe asociación de mayor mortalidad por COVID-19 con la presencia de DBT2 en esta población de adultos mayores. Estudio observacional retrospectivo (2018-2022) de historias clínicas (n=1020) de adultos mayores (≥65 años) atendidos en el Centro “San Ricardo Pampuri” de Villa Carlos Paz. Se analizaron estadísticamente mediante test ANOVA para los datos cuantitativos y Chi cuadrado para los categóricos usando Infostat (α=0.05). Se respetaron las normas éticas de confidencialidad y anonimato. Datos poblacionales: Distribución de sexos=62%masculino/38%femenino. 47% de la población padecía DBT2. Prevalencia total COVID-19: 46% de la población (469 casos) durante el período estudiado. Incidencias COVID-19 (%, pacientes DBT2 y no DBT2 respectivamente): 2020: 25,15 vs 15,78; 2021: 22,95 vs 14,73; 2022: 11,26 vs 5,38. Mortalidad COVID-19 (%): Total Promedio=0,63; en DBT2= 1,00 vs No DBT2=0,32. El 72% de los fallecidos tenían DBT2. Mortalidades y letalidades anuales por COVID-19, fueron mayores para aquellos con DBT2. En 2020 y 2021 COVID-19 fue la principal causa de muerte en la población estudiada. Exceso de Mortalidad: Mortalidad General promedio (%) pre-pandemia (2018-2019)=1,86 vs pandemia (2020-2022)=2,72 (incremento del 46%). Edad promedio fallecimiento por COVID-19: DBT2=76,4; No DBT2=84,1. El 83% de los pacientes diabéticos fallecidos (2020-2022) no estaban vacunados contra SARS-COV-2. La pandemia de COVID-19 tuvo un impacto negativo sobre los parámetros poblacionales estudiados, siendo estos incrementos mayores en el grupo con DBT2. Se observó un riesgo de mortalidad aumentado para COVID-19 en pacientes con DBT2. En el 2022 se registró una gran disminución de la incidencia, mortalidad y letalidad (gral y específica por COVID-19) respecto al año 2021. El mejoramiento de las variables en 2022 coincide con más del 80% de la población cubierta con vacunas (≥2 dosis) contra SARS-COV-2. Universidad Nacional Córdoba. Facultad de Ciencias Médicas. Secretaria de Ciencia y Tecnología 2023-10-19 info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion application/pdf https://revistas.unc.edu.ar/index.php/med/article/view/42712 Revista de la Facultad de Ciencias Médicas de Córdoba.; Vol. 80 (2023): Suplemento JIC XXIV Revista de la Facultad de Ciencias Médicas de Córdoba; Vol. 80 (2023): Suplemento JIC XXIV Revista da Faculdade de Ciências Médicas de Córdoba; v. 80 (2023): Suplemento JIC XXIV 1853-0605 0014-6722 spa https://revistas.unc.edu.ar/index.php/med/article/view/42712/42882 Derechos de autor 2023 Universidad Nacional de Córdoba http://creativecommons.org/licenses/by-nc/4.0 |